Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lifeforce Cryobank Sciences is a U.S.-based cord blood banking and newborn stem cell services company operating commercially through the Lifeforce Cryobanks and Cord for Life brands. The company focuses on collection, processing, cryopreservation, storage, and release of umbilical cord blood, and also offers cord tissue banking services. Its business is centered on stem cell banking infrastructure rather than a traditional therapeutic drug pipeline, serving both private family banking and public donation programs. The company highlights its proprietary PREMIERMAX processing approach and positions itself as a full-service cord blood bank supporting transplant, research, and clinical trial use of stored units.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lifeforce Cryobank Sciences.